NPCE
Neuropace Inc
14.30$
+0.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -67.7% | -52.5% | -54.4% | -81.0% | -30.1% | -22.5% | -11.0% | |
| 1.1% | 0.8% | 0.7% | 6.6% | 2.5% | 2.2% | 1.9% | |
| 3.9% | 3.4% | 9.5% | 18.3% | 14.6% | 12.9% | 11.1% | |
| 5.6% | 2.3% | 21.6% | 23.9% | – | – | – | |
| 0.0% | -5.0% | 0.8% | -10.5% | -3.8% | -6.8% | -4.0% | |
| 1.3% | 0.2% | 0.8% | 1.3% | 0.3% | 0.4% | 0.3% | |
| 9.8% | -26.2% | -189.0% | 52.3% | 35.2% | 11.3% | -0.3% | |
| – | – | 236.0% | -0.1% | -0.4% | 0.0% | -49.6% | |
| 57.7% | 59.5% | -9.1% | 0.0% | – | 0.0% | -2.1% | |
| 57.8% | 133.7% | 226.9% | 1.1% | 12.4% | 5.4% | 19.6% | |
| -0.1% | 55.0% | -16.5% | -27.6% | 17.5% | -5.8% | 8.3% | |
| -69.0% | -52.7% | -55.2% | -82.3% | -30.4% | -22.8% | -11.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.